{"result_id": "318001", "URL": "https://www.trialsitenews.com/a/australias-pharma-regulator-suppressed-troubling-report-about-pfizer-mrna-covid-19-vaccine-keeping-the-public-ignorant-to-hinder-hesitancy-2b495ee5", "timestamp": "2023-04-25 17:43:39 CEST+0200", "meta": {"description": "Transparent coverage of clinical research", "lang": "en", "keywords": "", "favicon": "", "canonical": "https://www.trialsitenews.com/a/australias-pharma-regulator-suppressed-troubling-report-about-pfizer-mrna-covid-19-vaccine-keeping-the-public-ignorant-to-hinder-hesitancy-2b495ee5", "encoding": "utf-8"}, "image": null, "domain": "www.trialsitenews.com", "title": "Australia\u2019s Pharma Regulator Suppressed Troubling Report about Pfizer mRNA COVID-19 Vaccine--Keeping the Public Ignorant to Hinder Hesitancy?", "cleaned_text": "", "opengraph": {"image": "https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/07de9848-893a-4555-09b3-c45418aeb300/public", "description": "Recently, Australia&rsquo;s Therapeutic Goods Administration (TGA) made a report from 2021 available to the public. Titled &ldquo;Nonclinical Evaluation Report BNT162b2 [mRNA] COVID-19 Vaccine (COMIRNATYTM)&rdquo; the document provides inputs from the preclinical work involving the Pfizer-BioNTech mRNA vaccine BNT162b2 (Comirnaty) via Pfizer Australia pty Ltd. &nbsp;A bombshell actually, the TGA, the agency that is supposed to &ldquo;safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods&rdquo; seemingly let the pharmaceutical company in this case dictate the risk-benefit analysis. At the height of the pandemic and the onset of the mass COVID-19 vaccination rollout starting February 22, 2021, the data in this document wasn&rsquo;t shared with the public. But why not? Would the data (or lack thereof) associated with this report lead to more vaccine hesitancy?&nbsp; \nBackground"}, "tags": [], "tweets": [], "movies": [], "links": [], "authors": [], "publish_date": null}